GuidelineGeneral thoracic and cardiovascular surgery2025
Guidelines for the treatment of empyema (The Japanese Association for Chest Surgery).
Guideline in General thoracic and cardiovascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Evidence-based, cost-effective management of empyema and chylothorax: An algorithm of the Journal of Trauma and Acute Care Surgery Emergency General Surgery Algorithms work group.The journal of trauma and acute care surgery · 2026Article
- Clinical outcomes and prognostic factors of open-window thoracostomy for empyema: a retrospective review of 40 patients.Surgery today · 2026Article
- Modified Negative Pressure Wound Therapy After Open-Window Thoracostomy for Empyema.Annals of thoracic surgery short reports · 2026Article
- Robotic-assisted lung decortication in the management of pleural space complications after lung transplant.JHLT open · 2026Article
- Community-acquired pseudomonas aeruginosa pneumonia in immunocompetent children: a study of 7 cases.BMC infectious diseases · 2026Article
- Late-onset fungal infection of the bronchial stump post-lung resection: a report of two rare cases ofAME case reports · 2026Article
- Adult Empyema Caused by Refractory Methicillin-ResistantInfection and drug resistance · 2026Article
- A Comprehensive Review of Pediatric Necrotizing Pneumonia.Children (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article translates the guidelines for the treatment of empyema established by the Japanese Association of Chest Surgery in 2023 from Japanese to English. These guidelines were developed by the Working Group on Guidelines for the Treatment of Empyema of our society, involving the establishment of clinical questions, conducting systematic reviews in accordance with the MINDS (Medical Information Distribution Service) Manual for Guideline Development 2020 version 3.0 and the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system, and determining the levels of recommendations. Furthermore, external evaluators provided assessments. Subsequently, the guidelines were finalized after receiving public comments from the members of the society. Even in the current era of advanced antibiotic therapy, empyema remains difficult to treat. However, the specific guideline for the treatment of empyema lacks in our country. Each institution is conducting clinical practices in its own way. Therefore, aiming to standardize the treatment of empyema, we have developed a practice guideline of empyema treatment. The pathophysiology of empyema is diverse, so empyema is classified into acute, chronic, and postoperative empyema. The recommended surgical treatment for each type of empyema is described, being categorized by the strength of recommendation, strength of evidence, and consensus rate.
Indexed as
Identifiers
39969668What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.